Products

View as  
 
250μl Transparent Pipette consilium Agilent

250μl Transparent Pipette consilium Agilent

Cotaus® consecratur evolutioni, productioni et mercaturae consumabilium pro scientiarum vita, diagnostica clinica. 250μl Transparens Pipette consilium pro Agilent ordinatur ad operastationum agilentium plene automated enzyme immunoassay et systemata spicula plene automata. Severum imperium habemus de variis consumabilibus faciendis et qualitatibus.

Exemplar numerus: CRAT250-A-TP
Brand nomen: Cotaus ®
Locum originis: Jiangsu, China
◉ Quality assurance: DNase gratis, Rnase gratis, pyrogen free
Ratio certificationis: ISO13485, CE, FDA
—‰ Accommodata instrumenta: Available pro agilenti plene automated enzyme immunoassay workstation, plene automated spicula systema; MGI, Agilent, Agilent Bravo
Price: Negotiation

Lege plusMitte Inquisitionem
1000μl Conductive Pipette consilium pro Tecan

1000μl Conductive Pipette consilium pro Tecan

Cotaus® Corporation fabrica in R&D posita est, consilium et fabricatio variorum automatorum consumamentorum in Sinis. Mμl Conductive Pipette Indicium For Tecan accurate pipetting observantiam praestanti verticali et CV pretii praebet.

—‰ Specification: 1000μl,conductive
◉ Model number: CRAT1000-T-P
Brand nomen: Cotaus ®
Locum originis: Jiangsu, China
Quality assurance: DNase Free, Rnase Free, Pyrogen Free
Ratio certificationis: ISO13485, CE, FDA
◉ Apta armorum: Compatible cum TECAN enzyme immunoassay workstation plene automated, TECAN Fluent, TECAN ADP, EVO100/EVO200
Price: Negotiation

Lege plusMitte Inquisitionem
<1>
Visne autoclave-pipette-tip? Cotaus est certus electionis tuae bene. notae sumus unum e auctoribus autoclave-pipette-tip Fabricis et Suppliers in Sinis. Officinas proprias habemus, producta nativus racionabili pretio possideri potest. Grata discount emendas emendas, quaestiones habes quae nos attingere possunt, opportune tibi respondebimus.
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept